Leflunomid Gebro 100 mg Compresse rivestite con film Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

leflunomid gebro 100 mg compresse rivestite con film

gebro pharma ag - leflunomidum - compresse rivestite con film - leflunomidum 100 mg, excipiens pro compresso haze. - aktive rheumatoide artrite - synthetika

Odomzo 200 mg Capsule rigide Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

odomzo 200 mg capsule rigide

sun pharma switzerland ltd - sonidegibum - capsule rigide - sonidegibum 200 mg ut sonidegibi diphosphas, crospovidonum, lactosum monohydricum 38.60 mg, poloxamerum 188, natrii laurilsulfas corresp. natrium 0.605 mg, magnesii stearas, silica colloidalis anhydrica, kapselhülle: gelatina, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), propylenglycolum q.s., pro capsula. - carcinoma a cellule basali - synthetika

Sivextro 200 mg Compresse rivestite con film Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

sivextro 200 mg compresse rivestite con film

msd merck sharp & dohme ag - tedizolidi phosphas - compresse rivestite con film - tedizolidi phosphas 200 mg, excipiens pro compresso obducto. - malattie infettive - synthetika

MVASI 100 mg/4 ml Concentrato per soluzione per Infusione Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

mvasi 100 mg/4 ml concentrato per soluzione per infusione

amgen switzerland ag - bevacizumabum - concentrato per soluzione per infusione - bevacizumabum 100 mg, trehalosum dihydricum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 5.42 mg. - onkologikum - biotechnologika

MVASI 400 mg/16 ml Concentrato per soluzione per Infusione Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

mvasi 400 mg/16 ml concentrato per soluzione per infusione

amgen switzerland ag - bevacizumabum - concentrato per soluzione per infusione - bevacizumabum 400 mg, trehalosum dihydricum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 21.68 mg. - onkologikum - biotechnologika

Zirabev 100 mg/4 ml Concentrato per soluzione per Infusione Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

zirabev 100 mg/4 ml concentrato per soluzione per infusione

pfizer ag - bevacizumabum - concentrato per soluzione per infusione - bevacizumabum 100 mg, acidum succinicum, saccharum, dinatrii edetas, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 2.32 mg. - onkologikum - biotechnologika

Zirabev 400 mg/16 ml Concentrato per soluzione per Infusione Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

zirabev 400 mg/16 ml concentrato per soluzione per infusione

pfizer ag - bevacizumabum - concentrato per soluzione per infusione - bevacizumabum 400 mg, acidum succinicum, saccharum, dinatrii edetas, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 9.29 mg. - onkologikum - biotechnologika

Rozlytrek European Union - Italian - EMA (European Medicines Agency)

rozlytrek

roche registration gmbh  - entrectinib - cancer; carcinoma, non-small-cell lung - agenti antineoplastici - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.

Lumeblue (previously known as Methylthioninium chloride Cosmo) European Union - Italian - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - cloruro di metiltioninio - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Rozlytrek 100 mg Capsule rigide Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

rozlytrek 100 mg capsule rigide

roche pharma (schweiz) ag - entrectinibum - capsule rigide - entrectinibum 100 mg, lactosum 65 mg, cellulosum microcristallinum, acidum tartaricum, hypromellosum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, kapselhülle: hypromellosum, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, e 132, pro capsula. - solide tumoren, nicht-kleinzelliges bronchialkarzinom (nsclc) - synthetika